I-Mab (IMAB)
USD 0.96
(42.81%)
USD 0.96
(42.81%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 894.81 Million CNY | -16.01% |
| 2022 | 1.06 Billion CNY | 2.28% |
| 2021 | 1.04 Billion CNY | 47.41% |
| 2020 | 706.64 Million CNY | -81.27% |
| 2019 | 3.77 Billion CNY | 13.25% |
| 2018 | 3.33 Billion CNY | 151.37% |
| 2017 | 1.32 Billion CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 124.94 Million CNY | 0.0% |
| 2023 FY | 894.81 Million CNY | -16.01% |
| 2023 Q3 | 894.81 Million CNY | -15.97% |
| 2023 Q2 | 1.06 Billion CNY | 0.0% |
| 2023 Q1 | 1.06 Billion CNY | -0.04% |
| 2023 Q4 | 894.81 Million CNY | 0.0% |
| 2022 FY | 1.06 Billion CNY | 2.28% |
| 2022 Q3 | 1.16 Billion CNY | 19.3% |
| 2022 Q1 | 975.49 Million CNY | -6.35% |
| 2022 Q2 | 975.49 Million CNY | 0.0% |
| 2022 Q4 | 1.06 Billion CNY | -8.46% |
| 2021 Q1 | 688.31 Million CNY | -2.59% |
| 2021 FY | 1.04 Billion CNY | 47.41% |
| 2021 Q4 | 1.04 Billion CNY | 0.0% |
| 2021 Q2 | 688.31 Million CNY | 0.0% |
| 2021 Q3 | 1.04 Billion CNY | 51.33% |
| 2020 Q4 | 706.64 Million CNY | 27.0% |
| 2020 Q3 | 556.43 Million CNY | 61.36% |
| 2020 Q2 | 344.84 Million CNY | 0.0% |
| 2020 Q1 | 344.84 Million CNY | -90.86% |
| 2020 FY | 706.64 Million CNY | -81.27% |
| 2019 Q3 | 549.62 Million CNY | -83.86% |
| 2019 Q2 | 3.4 Billion CNY | 593.71% |
| 2019 Q1 | 491.03 Million CNY | -85.26% |
| 2019 Q4 | 3.77 Billion CNY | 586.34% |
| 2019 FY | 3.77 Billion CNY | 13.25% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 FY | 3.33 Billion CNY | 151.37% |
| 2018 Q4 | 3.33 Billion CNY | 0.0% |
| 2017 FY | 1.32 Billion CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Agenus Inc. | 462.29 Million USD | -93.558% |
| Immix Biopharma, Inc. | 3.72 Million USD | -23942.536% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -2266.474% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -1133.083% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -280.424% |
| MiMedx Group, Inc. | 96.33 Million USD | -828.902% |
| Novavax, Inc. | 2.57 Billion USD | 65.213% |
| Seer, Inc. | 39.36 Million USD | -2173.113% |
| Acelyrin, Inc. | 86.35 Million USD | -936.225% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -157.44% |
| IO Biotech, Inc. | 17.55 Million USD | -4996.896% |
| Ardelyx, Inc. | 130.76 Million USD | -584.3% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -586.536% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -2443.73% |
| Fortress Biotech, Inc. | 165.93 Million USD | -439.241% |
| Fortress Biotech, Inc. | 165.93 Million USD | -439.241% |
| Geron Corporation | 146.12 Million USD | -512.352% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -87.046% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -1151.834% |
| Incyte Corporation | 1.59 Billion USD | 43.803% |
| Innoviva, Inc. | 568.55 Million USD | -57.384% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -36497.587% |
| ChromaDex Corporation | 26.5 Million USD | -3275.626% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -584.593% |
| MEI Pharma, Inc. | 8.35 Million USD | -10609.886% |
| NextCure, Inc. | 14.99 Million USD | -5866.6% |
| Onconetix, Inc. | 23.18 Million USD | -3760.124% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -13301.393% |
| GlycoMimetics, Inc. | 6.9 Million USD | -12864.379% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -3070.166% |
| Vaxcyte, Inc. | 167.44 Million USD | -434.378% |
| Precigen, Inc. | 41.64 Million USD | -2048.715% |
| Pharming Group N.V. | 244.07 Million USD | -266.616% |
| ContextLogic Inc. | 206 Million USD | -334.374% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -8098.745% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -1763.336% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -513.435% |
| AlloVir, Inc. | 45.01 Million USD | -1887.806% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -13442.806% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -480.507% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -68771.826% |
| Summit Therapeutics Inc. | 125.25 Million USD | -614.38% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -1424.796% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -9339.93% |
| Senti Biosciences, Inc. | 52.57 Million USD | -1602.1% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -587.206% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -45646.984% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -294.482% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -7292.261% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -1814.485% |
| Chimerix, Inc. | 19.74 Million USD | -4431.836% |
| PDS Biotechnology Corporation | 33.25 Million USD | -2590.422% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -2983.96% |
| CRISPR Therapeutics AG | 346.76 Million USD | -158.043% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -293.419% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -83.89% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -7405.544% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -1777.882% |
| Precision BioSciences, Inc. | 140.92 Million USD | -534.978% |
| Dyadic International, Inc. | 2.34 Million USD | -38129.151% |
| Elevation Oncology, Inc. | 34.28 Million USD | -2510.148% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -5402.128% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -228.628% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 77.909% |
| Aptorum Group Limited | 5.25 Million USD | -16922.172% |
| Bicycle Therapeutics plc | 224.41 Million USD | -298.736% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -66898.736% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -1692.131% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -25257.913% |
| GT Biopharma, Inc. | 6.63 Million USD | -13390.291% |
| Alkermes plc | 933.53 Million USD | 4.148% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -1347.118% |
| Jaguar Health, Inc. | 45.86 Million USD | -1850.924% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -9452.802% |
| AbCellera Biologics Inc. | 335.77 Million USD | -166.49% |
| PureTech Health plc | 125.58 Million USD | -612.526% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -25256.748% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -985.501% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -6123.041% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -3152.557% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -13442.806% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -3186.363% |
| AnaptysBio, Inc. | 364.28 Million USD | -145.634% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -3297.285% |
| ESSA Pharma Inc. | 3.49 Million USD | -25502.084% |
| Molecular Templates, Inc. | 31.17 Million USD | -2770.652% |
| Scopus BioPharma Inc. | 7.45 Million USD | -11903.742% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -80.949% |
| Vaxxinity, Inc. | 30.94 Million USD | -2791.711% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -2231.877% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -13369.983% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -2381.588% |
| Structure Therapeutics Inc. | 29.05 Million USD | -2980.138% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -9055.013% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -1201.032% |
| ImmuCell Corporation | 18.81 Million USD | -4655.832% |
| Lantern Pharma Inc. | 2.73 Million USD | -32561.126% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -9897.888% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -22037.828% |
| Opthea Limited | 264.6 Million USD | -238.173% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -600.214% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -490.588% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -549.355% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -238.444% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -964.922% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -3193.5% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -27639.429% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -1113.023% |
| Aptose Biosciences Inc. | 15.8 Million USD | -5560.244% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -8005.403% |
| Soligenix, Inc. | 7.27 Million USD | -12199.97% |
| Century Therapeutics, Inc. | 175.94 Million USD | -408.586% |
| Kura Oncology, Inc. | 51.66 Million USD | -1632.049% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -637.794% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -21550.399% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -13429.341% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -254.243% |
| Autolus Therapeutics plc | 263.9 Million USD | -239.063% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -8436.644% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -906.978% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -1807.953% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -153.591% |
| GRI Bio, Inc. | 2.69 Million USD | -33078.013% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -110427.122% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -2778.039% |
| IGM Biosciences, Inc. | 220.17 Million USD | -306.405% |
| INmune Bio, Inc. | 18.86 Million USD | -4643.988% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -248.883% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -3258.672% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -32816.753% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -27178.611% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -1430.769% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -830.554% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -238.003% |
| Coherus BioSciences, Inc. | 823.02 Million USD | -8.722% |
| Verastem, Inc. | 71.18 Million USD | -1157.022% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -1719.609% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -2219.485% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -1728.683% |
| Histogen Inc. | 5.69 Million USD | -15606.705% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -20303.365% |
| Surrozen, Inc. | 8.14 Million USD | -10886.016% |
| Organovo Holdings, Inc. | 2.74 Million USD | -32462.263% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -285000.587% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -1491.344% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -5319.156% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -1650.995% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -108115.994% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -606.105% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -8174.874% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -493.026% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -34218.857% |
| Apollomics, Inc. | 14.15 Million USD | -6222.412% |
| Amarin Corporation plc | 279.58 Million USD | -220.047% |
| Mesoblast Limited | 188.79 Million USD | -373.952% |
| Turnstone Biologics Corp. | 14.14 Million USD | -6224.647% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -394.95% |
| Synaptogenix, Inc. | 5.52 Million USD | -16082.585% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -13359.853% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -426.025% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -10356.829% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -50816.955% |
| Exelixis, Inc. | 678.44 Million USD | -31.891% |
| Better Therapeutics, Inc. | 23.84 Million USD | -3653.087% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -445.463% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -50.589% |
| NLS Pharmaceutics AG | 10.68 Million USD | -8278.22% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -55012.231% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -2198.69% |
| Gritstone bio, Inc. | 125.91 Million USD | -610.624% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -5997.104% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -17484.527% |
| Avid Bioservices, Inc. | 275.66 Million USD | -224.597% |
| Insmed Incorporated | 1.66 Billion USD | 46.153% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -11529.948% |
| MediWound Ltd. | 27.18 Million USD | -3191.319% |
| OmniAb, Inc. | 87.4 Million USD | -923.811% |
| Alector, Inc. | 487.66 Million USD | -83.487% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -121.787% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -4756.505% |
| Zai Lab Limited | 240.17 Million USD | -272.563% |
| Revance Therapeutics, Inc. | 630.05 Million USD | -42.02% |
| Aura Biosciences, Inc. | 29.22 Million USD | -2961.59% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -841.143% |
| Immunic, Inc. | 25.36 Million USD | -3427.322% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -1192.407% |
| Veracyte, Inc. | 93.71 Million USD | -854.781% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -34096.516% |
| FibroGen, Inc. | 585.72 Million USD | -52.769% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -5047.621% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -136914.834% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -15722.078% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 88.313% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -10814.991% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -964.972% |
| TG Therapeutics, Inc. | 169.08 Million USD | -429.208% |
| Galecto, Inc. | 5.89 Million USD | -15076.577% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -10701.678% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 65.826% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -3004.611% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -6989.858% |
| XBiotech Inc. | 8.39 Million USD | -10556.318% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -5997.104% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -1582.608% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -146.432% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -3228.415% |
| Theravance Biopharma, Inc. | 169 Million USD | -429.461% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 26.389% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -78.81% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 7.987% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -14736.596% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | -20.071% |
| NexImmune, Inc. | 5.08 Million USD | -17499.728% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -240833.079% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -29000.983% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 87.41% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -17261.385% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -3303.1% |
| Ainos, Inc. | 7.39 Million USD | -12001.488% |
| Pluri Inc. | 34.11 Million USD | -2523.156% |
| Prothena Corporation plc | 135.01 Million USD | -562.74% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -268.079% |
| Celularity Inc. | 102.92 Million USD | -769.348% |
| Rallybio Corporation | 9.43 Million USD | -9382.948% |
| Cue Biopharma, Inc. | 24.44 Million USD | -3560.507% |
| MeiraGTx Holdings plc | 319.99 Million USD | -179.636% |
| Omeros Corporation | 403.25 Million USD | -121.899% |
| Humacyte, Inc. | 114.67 Million USD | -680.288% |
| Immunocore Holdings plc | 228.15 Million USD | -292.189% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -18255.097% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -1066.029% |
| Blueprint Medicines Corporation | 918.64 Million USD | 2.594% |
| CalciMedica, Inc. | 4.02 Million USD | -22114.772% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -5027.269% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -942.697% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -222.114% |
| Pulmatrix, Inc. | 15.96 Million USD | -5505.532% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -5573.055% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -3536.556% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -256.771% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -1661.924% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 26.088% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -2715.376% |
| Nutriband Inc. | 1.07 Million USD | -82835.883% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -8315.414% |
| Vor Biopharma Inc. | 59.1 Million USD | -1413.96% |
| Roivant Sciences Ltd. | 773.95 Million USD | -15.616% |
| Evogene Ltd. | 17.99 Million USD | -4873.936% |
| ProKidney Corp. | 29.21 Million USD | -2962.743% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -1143.156% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -126826.607% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 52.628% |
| CorMedix Inc. | 11.91 Million USD | -7408.361% |
| BioLineRx Ltd. | 50.7 Million USD | -1664.844% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -498.7% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -911.76% |
| Atai Life Sciences N.V. | 49.16 Million USD | -1720.127% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -2772.375% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -4881.689% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -617.939% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -15726.158% |
| MediciNova, Inc. | 3.89 Million USD | -22893.674% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -4795.295% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -59385.88% |
| GeoVax Labs, Inc. | 3.51 Million USD | -25321.626% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -125.246% |
| Biomea Fusion, Inc. | 30.69 Million USD | -2815.644% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 67.124% |
| Mereo BioPharma Group plc | 15.96 Million USD | -5505.883% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -2767.892% |
| Absci Corporation | 58.3 Million USD | -1434.733% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -4597.664% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -2690.877% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -1112.645% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -922.84% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -2549.722% |
| Allakos Inc. | 74.79 Million USD | -1096.383% |
| Imunon, Inc. | 8.53 Million USD | -10389.639% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -3876.761% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -679.371% |
| BioAtla, Inc. | 48.98 Million USD | -1726.667% |
| NLS Pharmaceutics AG | 10.68 Million USD | -8278.22% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -32099.028% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -585.133% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -6194.836% |
| XOMA Corporation | 145.58 Million USD | -514.652% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -2557.986% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -1201.373% |
| aTyr Pharma, Inc. | 31.59 Million USD | -2731.949% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -1347.376% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -1890.017% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -1748.707% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -31078.084% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -10868.485% |
| Akari Therapeutics, Plc | 4.58 Million USD | -19420.31% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -4945.985% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 45.751% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -221438.321% |
| UroGen Pharma Ltd. | 243.52 Million USD | -267.444% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -178.682% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -32302.397% |
| Orgenesis Inc. | 35.53 Million USD | -2418.112% |
| Entera Bio Ltd. | 1.37 Million USD | -64788.397% |
| GH Research PLC | 6.7 Million USD | -13253.395% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -13058.985% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -4653.06% |
| Xencor, Inc. | 283.55 Million USD | -215.564% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -29870.141% |
| Replimune Group, Inc. | 113.21 Million USD | -690.371% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -23716.376% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -764.301% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -221438.321% |
| Portage Biotech Inc. | 4.45 Million USD | -20008.112% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -59385.88% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -3782.043% |
| OncoCyte Corporation | 49.29 Million USD | -1715.106% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -21530.485% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -112104.257% |
| Purple Biotech Ltd. | 10 Million USD | -8843.638% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -15365.105% |
| scPharmaceuticals Inc. | 57.26 Million USD | -1462.688% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -7123.196% |
| HilleVax, Inc. | 78.9 Million USD | -1033.978% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -17619.03% |
| Tharimmune, Inc. | 1.81 Million USD | -49199.632% |
| Genprex, Inc. | 3.25 Million USD | -27397.044% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -3199.572% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -16989.591% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -434274.272% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -249465.191% |
| OKYO Pharma Limited | 7.42 Million USD | -11958.073% |
| Savara Inc. | 37.19 Million USD | -2305.923% |
| Curis, Inc. | 57.61 Million USD | -1453.168% |
| Daré Bioscience, Inc. | 26.32 Million USD | -3298.465% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -2182.693% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -61867.521% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -4198.05% |
| BeiGene, Ltd. | 2.23 Billion USD | 59.941% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -4103.003% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -241.014% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -4106.125% |
| Erasca, Inc. | 78.61 Million USD | -1038.277% |
| bluebird bio, Inc. | 424.62 Million USD | -110.73% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -136459.827% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 52.657% |
| DBV Technologies S.A. | 42.8 Million USD | -1990.68% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -136459.827% |
| Moderna, Inc. | 4.57 Billion USD | 80.428% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -12692.152% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -53934.481% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -5142.009% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -52.152% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -618.695% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -3161.33% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -2354.496% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -1508.36% |
| MacroGenics, Inc. | 154.2 Million USD | -480.266% |
| RenovoRx, Inc. | 4.46 Million USD | -19936.073% |
| Adicet Bio, Inc. | 37.12 Million USD | -2310.59% |
| Prime Medicine, Inc. | 60.78 Million USD | -1372.213% |
| Aditxt, Inc. | 28.53 Million USD | -3036.215% |
| Adagene Inc. | 45.16 Million USD | -1881.014% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -495088.737% |
| Quantum-Si incorporated | 26.63 Million USD | -3260.035% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | -28.276% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -29310.986% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -678.36% |
| SciSparc Ltd. | 1.59 Million USD | -56001.003% |
| Vericel Corporation | 127.7 Million USD | -600.686% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -15979.57% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -948.302% |
| Generation Bio Co. | 171.63 Million USD | -421.36% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -7647.281% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -2039.11% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -254.103% |
| Invivyd, Inc. | 51.71 Million USD | -1630.341% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -872.864% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -13655.211% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -1085.243% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -87540.646% |
| 2seventy bio, Inc. | 310.12 Million USD | -188.531% |
| ADMA Biologics, Inc. | 193.97 Million USD | -361.3% |
| Clene Inc. | 38.95 Million USD | -2197.273% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -2376.447% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -248.208% |
| GeoVax Labs, Inc. | 3.51 Million USD | -25321.626% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -370.302% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -7246.764% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -351.191% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -7237.644% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -1759.889% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -1593.403% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -141.936% |
| Evaxion Biotech A/S | 17.61 Million USD | -4979.109% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -456.028% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -484.134% |
| Trevena, Inc. | 48.26 Million USD | -1754.069% |
| Surrozen, Inc. | 8.14 Million USD | -10886.016% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -4043.603% |
| Cingulate Inc. | 10.36 Million USD | -8536.451% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -32438.582% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -2299.472% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -24849.282% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -6704.646% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -182.096% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -3500.994% |
| Clearmind Medicine Inc. | 3.61 Million USD | -24686.953% |
| Kronos Bio, Inc. | 54.2 Million USD | -1550.912% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -1802.113% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -3831.553% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -4358.228% |
| Statera Biopharma, Inc. | 22.67 Million USD | -3845.992% |
| ImmunityBio, Inc. | 1.09 Billion USD | 17.937% |
| Korro Bio, Inc. | 51.75 Million USD | -1629.037% |
| Kineta, Inc. | 7.22 Million USD | -12290.072% |
| BioVie Inc. | 9.7 Million USD | -9122.83% |
| Codexis, Inc. | 49.94 Million USD | -1691.557% |
| Celularity Inc. | 102.92 Million USD | -769.348% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -829.703% |
| Celcuity Inc. | 51.45 Million USD | -1639.183% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -259119.743% |
| Cibus, Inc. | 206.11 Million USD | -334.128% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -2006.677% |
| IN8bio, Inc. | 8.77 Million USD | -10100.764% |
| Kodiak Sciences Inc. | 213.59 Million USD | -318.937% |
| Annexon, Inc. | 47.11 Million USD | -1799.085% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -899.331% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -828.497% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -6436.716% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 65.629% |
| Eyenovia, Inc. | 19.78 Million USD | -4423.753% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -405.297% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -11549.668% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -3613.063% |
| Arcellx, Inc. | 339.75 Million USD | -163.372% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -7420.684% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -264.426% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -9257.011% |
| Moolec Science SA | 13.94 Million USD | -6316.552% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -1973.626% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -1670.781% |
| Royalty Pharma plc | 6.29 Billion USD | 85.791% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -2149.625% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -303837.759% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -36270.262% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -373.055% |
| Humacyte, Inc. | 114.67 Million USD | -680.288% |
| 89bio, Inc. | 59.96 Million USD | -1392.272% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -3281.366% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -74716.973% |
| Genelux Corporation | 8.42 Million USD | -10527.209% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -12951.502% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -556.41% |
| Notable Labs, Ltd. | 4.42 Million USD | -20112.582% |
| Liquidia Corporation | 73.13 Million USD | -1123.456% |
| Mustang Bio, Inc. | 17.61 Million USD | -4978.671% |
| Immunovant, Inc. | 48.95 Million USD | -1727.824% |
| Quantum-Si incorporated | 26.63 Million USD | -3260.035% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -2231.269% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -28736.964% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -1111.48% |
| Acasti Pharma Inc. | 11.55 Million USD | -7642.589% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -3857.987% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -32816.753% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -2326.474% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -65557.721% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -14578.658% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -3503.024% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -3759.606% |
| PepGen Inc. | 34.63 Million USD | -2483.844% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -7268.338% |
| United Therapeutics Corporation | 1.18 Billion USD | 24.31% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -12712.3% |
| Solid Biosciences Inc. | 38.45 Million USD | -2226.723% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -10356.829% |
| Immuneering Corporation | 12 Million USD | -7351.57% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -285000.587% |
| Silo Pharma, Inc. | 1.56 Million USD | -56920.844% |
| Belite Bio, Inc | 4.21 Million USD | -21149.371% |
| XOMA Corporation | 145.58 Million USD | -514.652% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -36753.83% |
| Bionomics Limited | 10.15 Million USD | -8708.304% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -4063.655% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -3805.255% |
| uniQure N.V. | 624.01 Million USD | -43.395% |
| Cassava Sciences, Inc. | 14.19 Million USD | -6203.706% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -495088.737% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -425.79% |
| Forte Biosciences, Inc. | 3.66 Million USD | -24308.374% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -343288.095% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -13162.354% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -11549.668% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -5047.621% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -8367.174% |
| Altimmune, Inc. | 16.54 Million USD | -5309.655% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -44.86% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -3805.255% |
| Compugen Ltd. | 55.77 Million USD | -1504.323% |
| Peak Bio, Inc. | 20.75 Million USD | -4211.643% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -710.055% |
| Benitec Biopharma Inc. | 4.96 Million USD | -17933.273% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -466.899% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -1090.32% |
| Zura Bio Limited | 21.29 Million USD | -4102.569% |
| PolyPid Ltd. | 17.46 Million USD | -5022.573% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -696.102% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -1090.32% |
| Instil Bio, Inc. | 99.8 Million USD | -796.595% |
| argenx SE | 444.95 Million USD | -101.103% |
| Immunome, Inc. | 28.65 Million USD | -3022.378% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -10633.009% |
| Verona Pharma plc | 58.84 Million USD | -1420.727% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -6082.623% |
| Shattuck Labs, Inc. | 14.85 Million USD | -5922.014% |
| CervoMed Inc. | 2.59 Million USD | -34372.196% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -18258.863% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -6925.84% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -8393.697% |
| Moolec Science SA | 13.94 Million USD | -6316.552% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -38082.61% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -1509.509% |
| Design Therapeutics, Inc. | 11.95 Million USD | -7384.2% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -6954.644% |
| NeurAxis, Inc. | 1.91 Million USD | -46681.657% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -2198.631% |
| Lumos Pharma, Inc. | 13.33 Million USD | -6611.25% |
| Achilles Therapeutics plc | 19.08 Million USD | -4588.065% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -6082.623% |
| 180 Life Sciences Corp. | 5.38 Million USD | -16509.918% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -3693.503% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -3831.553% |
| Nutriband Inc. | 1.07 Million USD | -82835.883% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -2824.41% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -6066.432% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -122.993% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -2655.554% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -6757.264% |
| Palisade Bio, Inc. | 2.73 Million USD | -32569.259% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -16934.285% |
| Beam Therapeutics Inc. | 478.38 Million USD | -87.048% |
| Neurogene Inc. | 36.54 Million USD | -2348.25% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -124.855% |
| AEON Biopharma, Inc. | 159.88 Million USD | -459.645% |
| Sesen Bio, Inc. | 30.98 Million USD | -2787.978% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -3346.751% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -11670.397% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -357.147% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -365.909% |
| Athira Pharma, Inc. | 30.05 Million USD | -2877.047% |
| Vaccinex, Inc. | 5.94 Million USD | -14959.088% |
| HCW Biologics Inc. | 15.05 Million USD | -5844.821% |
| XOMA Corporation | 145.58 Million USD | -514.652% |
| Nektar Therapeutics | 267.04 Million USD | -235.077% |
| Arvinas, Inc. | 644.6 Million USD | -38.816% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -4945.985% |
| Merus N.V. | 102.15 Million USD | -775.969% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -511.419% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -840.718% |
| Rezolute, Inc. | 11.73 Million USD | -7525.797% |
| Clene Inc. | 38.95 Million USD | -2197.273% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -31325.767% |
| BeyondSpring Inc. | 48.26 Million USD | -1753.801% |
| Synlogic, Inc. | 32.89 Million USD | -2620.204% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -6023.39% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -54661.995% |
| Peak Bio, Inc. | 20.75 Million USD | -4211.643% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -1310.062% |
| Krystal Biotech, Inc. | 39.71 Million USD | -2153.137% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -137.575% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -798.684% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -206684.663% |
| MannKind Corporation | 721.36 Million USD | -24.044% |
| Ikena Oncology, Inc. | 22.33 Million USD | -3906.317% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -42796.021% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -772.22% |
| Gossamer Bio, Inc. | 249.14 Million USD | -259.15% |
| CohBar, Inc. | 1.03 Million USD | -86469.089% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -8271.326% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -4597.664% |
| Legend Biotech Corporation | 589.93 Million USD | -51.68% |
| Mural Oncology plc | 37.92 Million USD | -2259.236% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -574.637% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -38883.947% |
| Disc Medicine, Inc. | 22.87 Million USD | -3811.742% |
| Champions Oncology, Inc. | 28.03 Million USD | -3091.764% |
| REGENXBIO Inc. | 262.22 Million USD | -241.234% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -26536.417% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -7039.07% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -6561.97% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -4119.811% |
| Vaxart, Inc. | 34.02 Million USD | -2529.863% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -4288.638% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -3036.179% |
| Cellectis S.A. | 249.57 Million USD | -258.534% |
| Longeveron Inc. | 5.33 Million USD | -16666.18% |
| Repare Therapeutics Inc. | 41.81 Million USD | -2039.724% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 62.797% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -1382.26% |
| Revolution Medicines, Inc. | 262.39 Million USD | -241.014% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -42368.486% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -10273.418% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -7482.501% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -6271.936% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -41499.768% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 82.624% |
| Denali Therapeutics Inc. | 122.96 Million USD | -627.708% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -15979.57% |
| Veru Inc. | 32.81 Million USD | -2627.026% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -12926.802% |
| Cingulate Inc. | 10.36 Million USD | -8536.451% |
| Passage Bio, Inc. | 39.26 Million USD | -2179.076% |
| Context Therapeutics Inc. | 4.19 Million USD | -21247.134% |
| Exicure, Inc. | 8.54 Million USD | -10366.85% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -2932.435% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -8433.387% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -3959.757% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -449.011% |
| Nuvalent, Inc. | 31.82 Million USD | -2711.837% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -13965.757% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -1319.839% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -4871.172% |
| OmniAb, Inc. | 87.4 Million USD | -923.811% |
| Anew Medical, Inc. | 8.24 Million USD | -10756.986% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -2236.987% |
| Lipocine Inc. | 2.63 Million USD | -33902.171% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -3305.949% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -2125.234% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -3258.672% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -938.618% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -16467.506% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -981.382% |
| Ocugen, Inc. | 23.98 Million USD | -3631.022% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -1828.181% |
| Q32 Bio Inc. | 233.12 Million USD | -283.828% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -9769.965% |
| Alumis Inc. Common Stock | 53.5 Million USD | -1572.481% |
| Equillium, Inc. | 27.95 Million USD | -3100.669% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -333.13% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -15803.044% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -14490.179% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -468.762% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -1188.74% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -8871.255% |
| Dominari Holdings Inc. | 4.63 Million USD | -19205.523% |
| Edesa Biotech, Inc. | 1.84 Million USD | -48487.805% |
| vTv Therapeutics Inc. | 29.56 Million USD | -2926.384% |
| Bio-Techne Corporation | 744.34 Million USD | -20.215% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -609.61% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -159.775% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -2105.326% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -2990.137% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -868.83% |
| Nkarta, Inc. | 105.6 Million USD | -747.359% |
| BioCardia, Inc. | 4.59 Million USD | -19394.793% |
| Iterum Therapeutics plc | 32.66 Million USD | -2639.609% |